Examkin

Question

Difficulty: Very hardEndocrinology and Metabolism

A 6464-year-old man presents to the emergency department with a 55-day history of profound fatigue, severe headache, and nausea. He has a history of metastatic melanoma and has been receiving combination immunotherapy with nivolumab and ipilimumab for the past 1212 weeks. His blood pressure is 96/6096/60 mm Hg, and his heart rate is 9292/min. Physical examination reveals no focal neurologic deficits, no orthostatic blood pressure changes, and normal skin pigmentation.

Laboratory studies show:
Sodium: 130130 mEq/L
Potassium: 4.14.1 mEq/L
Glucose: 6565 mg/dL
Thyroid-stimulating hormone (TSH): 0.20.2 mIU/L (Normal: 0.4−4.20.4-4.2 mIU/L)
Free T4: 0.50.5 ng/dL (Normal: 0.9−1.70.9-1.7 ng/dL)
Morning (8:00 AM) serum cortisol: 2.12.1 μ\mu g/dL (Normal: 5−255-25 μ\mu g/dL)

Magnetic resonance imaging (MRI) of the brain reveals diffuse enlargement of the pituitary gland with stalk thickening.

Which of the following is the most appropriate management strategy for this patient?

  1. Initiate hydrocortisone therapy prior to starting levothyroxineAnswer
  2. B
    Initiate levothyroxine therapy immediately to address the severe hypothyroidism
  3. C
    Add fludrocortisone therapy to correct the hyponatremia and hypotension
  4. D
    Titrate future levothyroxine doses to maintain the serum TSH level within the normal reference range
  5. E
    Administer intravenous hypertonic saline to acutely correct the hyponatremia

Answer

Initiate hydrocortisone therapy prior to starting levothyroxine
The correct strategy addresses panhypopituitarism caused by immune checkpoint inhibitor-induced hypophysitis. The patient has central adrenal insufficiency (low cortisol) and central hypothyroidism (inappropriately low TSH with low free T4). The cardinal rule of endocrinology in panhypopituitarism is that glucocorticoid replacement (hydrocortisone) MUST be initiated before thyroid hormone replacement. Thyroid hormone increases the basal metabolic rate and accelerates the hepatic clearance of cortisol. If levothyroxine is given first to a cortisol-deficient patient, it can precipitate a fatal acute adrenal crisis (severe hypotension, shock, and vascular collapse).

Step-by-Step Solution

1
Analyze the patient's history and imaging findings.
The patient is on immune checkpoint inhibitors (ipilimumab/nivolumab) and has MRI evidence of pituitary enlargement.
This highly suggests immune checkpoint inhibitor-induced hypophysitis, an autoimmune inflammation of the pituitary gland.
2
Interpret the laboratory findings in the context of pituitary disease.
Low TSH with low free T4 indicates central hypothyroidism. Low morning cortisol with normal potassium and lack of hyperpigmentation indicates central adrenal insufficiency.
Hypophysitis frequently causes panhypopituitarism, leading to concurrent deficiencies in multiple anterior pituitary hormones (ACTH and TSH).
3
Determine the physiological interaction between the required hormone replacements.
The patient requires both glucocorticoids (hydrocortisone) and thyroid hormone (levothyroxine). However, thyroid hormone increases the metabolic clearance of cortisol.
Administering levothyroxine first in a patient with profound cortisol deficiency will rapidly clear what little cortisol they have left, precipitating a life-threatening adrenal crisis.
4
Establish the correct management sequence.
Glucocorticoids must be administered first.
Hydrocortisone replacement stabilizes the patient's hemodynamics and prevents adrenal crisis before the metabolic rate is increased by levothyroxine.

Key Concept

In patients with central panhypopituitarism (e.g., secondary to hypophysitis), glucocorticoid replacement must ALWAYS precede thyroid hormone replacement to avoid precipitating an acute adrenal crisis.
Rate this question

Topics

Endocrinology and Metabolism

More questions from this topic